Trials / Recruiting
RecruitingNCT06734286
Working Memory Training in Patients with Mild Cognitive Impairment
CogMed Intervention Targeting Working Memory in Patients with Mild Cognitive Impairment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- St. Joseph's Hospital and Medical Center, Phoenix · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).
Detailed description
The goal of this study is to conduct a pilot clinical trial aimed at comparing the effects of CogMed intervention plus Treatment As Usual (TAU) versus TAU alone in patients with Mild Cognitive Impairment (MCI). Based on our preliminary data from brain health program, the primary hypothesis is that the CogMed intervention may improve the CogMed measures and possibly working memory. This may improve sense of self-efficacy and lead to a decrease in perceived stress, thereby demonstrating possible transfer of cognitive benefits to biobehavioral construct of perceived stress. Additionally, the study aims to demonstrate the feasibility of collecting p-Tau 217, a blood based Alzheimer's Disease biomarker, from MCI patients. Though no significant changes in pTau 217 are expected due to the short duration of the study, the goal is to successfully recruit 10 MCI patients (5 in the intervention group and 5 in the control group) who are willing to undergo blood draws for p-Tau 217 level determination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CogMed | CogMed which is a computerized working memory training program developed by Karolinska University. |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2025-06-30
- Completion
- 2025-09-30
- First posted
- 2024-12-16
- Last updated
- 2024-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06734286. Inclusion in this directory is not an endorsement.